DekaBank Deutsche Girozentrale’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Buy
280,330
+159
+0.1% +$8.85K 0.03% 361
2025
Q1
$19.8M Sell
280,171
-159
-0.1% -$11.3K 0.04% 311
2024
Q4
$18.6M Hold
280,330
0.03% 334
2024
Q3
$19.7M Sell
280,330
-761
-0.3% -$53.4K 0.04% 330
2024
Q2
$23.5M Buy
281,091
+920
+0.3% +$76.9K 0.04% 293
2024
Q1
$24.7M Sell
280,171
-11,746
-4% -$1.04M 0.05% 291
2023
Q4
$28.3M Sell
291,917
-6,478
-2% -$627K 0.06% 267
2023
Q3
$26.6M Sell
298,395
-20,230
-6% -$1.8M 0.06% 268
2023
Q2
$28.6M Sell
318,625
-23,246
-7% -$2.09M 0.06% 263
2023
Q1
$32.8M Buy
341,871
+45,304
+15% +$4.35M 0.08% 233
2022
Q4
$30.3M Buy
296,567
+7,280
+3% +$743K 0.08% 233
2022
Q3
$24.5M Buy
289,287
+3,750
+1% +$317K 0.07% 245
2022
Q2
$23.8M Buy
285,537
+30,804
+12% +$2.56M 0.07% 245
2022
Q1
$19.9M Sell
254,733
-5,735
-2% -$448K 0.05% 288
2021
Q4
$23.3M Sell
260,468
-30,034
-10% -$2.69M 0.06% 262
2021
Q3
$22.3M Buy
290,502
+14,333
+5% +$1.1M 0.06% 244
2021
Q2
$22.9M Buy
276,169
+2,437
+0.9% +$202K 0.07% 247
2021
Q1
$20.5M Buy
273,732
+18,131
+7% +$1.36M 0.07% 246
2020
Q4
$22.1M Buy
255,601
+3,437
+1% +$297K 0.08% 225
2020
Q3
$18.9M Buy
252,164
+127,295
+102% +$9.57M 0.08% 213
2020
Q2
$15.2M Sell
124,869
-572
-0.5% -$69.6K 0.1% 156
2020
Q1
$10.2M Sell
125,441
-14,545
-10% -$1.18M 0.08% 176
2019
Q4
$11.9M Sell
139,986
-191,097
-58% -$16.2M 0.07% 204
2019
Q3
$22.6M Sell
331,083
-127,341
-28% -$8.71M 0.14% 161
2019
Q2
$38.6M Buy
458,424
+375,760
+455% +$31.6M 0.19% 136
2019
Q1
$8.29M Sell
82,664
-87,349
-51% -$8.76M 0.05% 340
2018
Q4
$14.3M Buy
170,013
+87,349
+106% +$7.36M 0.09% 212
2018
Q3
$8.29M Buy
82,664
+10,098
+14% +$1.01M 0.05% 343
2018
Q2
$6.71M Sell
72,566
-49,059
-40% -$4.53M 0.04% 355
2018
Q1
$9.77M Sell
121,625
-32,455
-21% -$2.61M 0.07% 290
2017
Q4
$12.9M Hold
154,080
0.1% 220
2017
Q3
$12.9M Sell
154,080
-584
-0.4% -$48.7K 0.1% 221
2017
Q2
$14M Sell
154,664
-24,087
-13% -$2.18M 0.11% 202
2017
Q1
$16M Buy
178,751
+60,341
+51% +$5.39M 0.15% 149
2016
Q4
$9.96M Buy
118,410
+2,100
+2% +$177K 0.11% 195
2016
Q3
$10.8M Buy
116,310
+884
+0.8% +$82K 0.12% 193
2016
Q2
$9.05M Buy
115,426
+11,824
+11% +$927K 0.1% 212
2016
Q1
$8.11M Buy
103,602
+1,320
+1% +$103K 0.1% 221
2015
Q4
$10.8M Sell
102,282
-3,200
-3% -$338K 0.12% 168
2015
Q3
$11.1M Buy
105,482
+7,094
+7% +$747K 0.14% 158
2015
Q2
$13.5M Buy
98,388
+6,700
+7% +$916K 0.16% 125
2015
Q1
$11.4M Sell
91,688
-3,120
-3% -$389K 0.14% 155
2014
Q4
$8.7M Sell
94,808
-6,047
-6% -$555K 0.11% 191
2014
Q3
$7.39M Buy
100,855
+3,929
+4% +$288K 0.1% 201
2014
Q2
$6.07M Sell
96,926
-1,521
-2% -$95.3K 0.09% 220
2014
Q1
$6.56M Buy
98,447
+6,200
+7% +$413K 0.1% 200
2013
Q4
$6.4M Buy
92,247
+1,950
+2% +$135K 0.11% 175
2013
Q3
$6.65M Buy
90,297
+6,153
+7% +$453K 0.12% 158
2013
Q2
$4.76M Buy
+84,144
New +$4.76M 0.09% 175